Samuel Leung

Samuel Leung

UNVERIFIED PROFILE

Are you Samuel Leung?   Register this Author

Register author
Samuel Leung

Samuel Leung

Publications by authors named "Samuel Leung"

Are you Samuel Leung?   Register this Author

84Publications

2753Reads

25Profile Views

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.

Breast Cancer Res Treat 2020 Jan 14;179(1):3-10. Epub 2019 Sep 14.

Genetic Pathology Evaluation Centre and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05438-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985067PMC
January 2020

Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.

Int J Gynecol Cancer 2020 01 25;30(1):100-106. Epub 2019 Nov 25.

Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-000793DOI Listing
January 2020

Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers.

Hum Pathol 2019 Oct 18;92:39-47. Epub 2019 Jun 18.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V5Z 1L3, Canada; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.06.001DOI Listing
October 2019

Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.

Gynecol Oncol 2019 06 25;153(3):487-495. Epub 2019 Mar 25.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.098DOI Listing
June 2019

Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.

Int J Gynecol Pathol 2019 May 13. Epub 2019 May 13.

Department of Pathology and Laboratory Medicine, University of British Columbia (J.X.J., B.T.-C, B.G., D.G.H., L.N.H.) Department of Molecular Oncology, British Columbia Cancer Research Centre (D.R.C.) Genetic Pathology Evaluation Centre (S.L., A.S.C., C.C.) Department of Pathology, Vancouver General Hospital (B.G., L.N.H.), Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9910
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000609DOI Listing
May 2019

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma.

Clin Cancer Res 2019 Apr 6;25(8):2537-2548. Epub 2018 Dec 6.

Departments of Gynecology and Obstetrics, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3241DOI Listing
April 2019

Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.

Histopathology 2019 Feb;74(3):452-462

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13772
Publisher Site
http://dx.doi.org/10.1111/his.13772DOI Listing
February 2019

Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.

Lab Invest 2019 01 4;99(1):107-117. Epub 2018 Sep 4.

Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41374-018-0123-7DOI Listing
January 2019

TIM-3 expression in breast cancer.

Oncoimmunology 2018 23;7(11):e1502128. Epub 2018 Aug 23.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1502128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019PMC
August 2018

Mortality and Hospitalizations in Intensive Dialysis: A Systematic Review and Meta-Analysis.

Can J Kidney Health Dis 2018 10;5:2054358117749531. Epub 2018 Jan 10.

Department of Nephrology, Humber River Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2054358117749531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768251PMC
January 2018

Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.

Histopathology 2017 Aug 23;71(2):238-246. Epub 2017 May 23.

Department of Pathology and Laboratory Medicine, University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13205DOI Listing
August 2017

Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.

Clin Breast Cancer 2017 07 20;17(4):e215-e224. Epub 2017 Jan 20.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.01.002DOI Listing
July 2017

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.

Cancer 2017 03 6;123(5):802-813. Epub 2017 Jan 6.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30496DOI Listing
March 2017

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.

Gynecol Oncol 2016 10 14;143(1):46-53. Epub 2016 Jul 14.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, 2775 Laurel St., 6th Floor, Vancouver, British Columbia V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521211PMC
October 2016

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Int J Gynecol Pathol 2016 Sep;35(5):430-41

Calgary Laboratory Services/Alberta Health Services (M.K., P.F.R., C.N., S.L.), Department of Pathology and Laboratory Medicine, Foothill Medical Center, University of Calgary, Calgary Department of Laboratory Medicine and Pathology (X.L., C.A.E., C.-H.L.), University of Alberta, Edmonton, AB Centre de recherche du (K.R., C.L.P., L.M., M.d.L., D.P., A.-M.M.M.), Centre hospitalier de l'Université de Montréal (CRCHUM) Departments of Pathology (K.R.) Obstetric-Gynecology (D.P.) Medicine (A.-M.M.M.), Université de Montréal Institut du cancer de Montréal (C.L.P., L.M., M.d.L., D.P., A.-M.M.M.), Montreal, QC Department of Pathology (S.L., D.H., C.B.G.), University of British Columbia, Vancouver, BC Department of Cellular and Molecular Medicine (B.V.), University of Ottawa, ON, Canada Department of Pathology (P.F.R.), Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania Department of Health Sciences Research (E.L.G.), Mayo Clinic, Rochester, Minnesota Department of Preventive Medicine (S.J.R.), Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California Department of Pathology and Cytology (J.W.C.), Institution for Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden Department of Public Health Sciences (L.E.K.), College of Medicine, Medical University of South Carolina Hollings Cancer Center (L.E.K.), Medical University of South Carolina, Charleston, South Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978603PMC
September 2016

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.

Clin Cancer Res 2016 06 13;22(12):2865-73. Epub 2016 Jan 13.

Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/01/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2233DOI Listing
June 2016

A Case of Beare-Stevenson Syndrome with Unusual Manifestations.

Am J Case Rep 2016 Apr 15;17:254-8. Epub 2016 Apr 15.

, Albert Einstein College of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835158PMC
http://dx.doi.org/10.12659/ajcr.897177DOI Listing
April 2016

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.

Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3689-zDOI Listing
February 2016

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.

Cell Metab 2015 Oct 10;22(4):577-89. Epub 2015 Sep 10.

Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2015.08.007DOI Listing
October 2015

STAT1 drives tumor progression in serous papillary endometrial cancer.

Cancer Res 2014 Nov 29;74(22):6519-30. Epub 2014 Sep 29.

Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0847DOI Listing
November 2014

An international Ki67 reproducibility study.

J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.

Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888090PMC
December 2013

HNF-1β in ovarian carcinomas with serous and clear cell change.

Int J Gynecol Pathol 2013 Nov;32(6):541-6

Department of Pathology (D.D., R.A.S.), Memorial Sloan-Kettering Cancer Center, New York, New York Sunnybrook Health Sciences Centre (G.H.), Toronto, ON Department of Pathology and Laboratory Medicine (J.A.I., S.L., C.B.G.), University of British Columbia and Vancouver General Hospital, Vancouver, BC Department of Laboratory Medicine and Pathology (C.A.E.), Royal Alexandra Hospital, University of Alberta, Edmonton, AB, Canada Department of Pathology (T.A.L.), Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e318273fd07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421549PMC
November 2013

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Breast Cancer Res 2012 Mar 15;14(2):R48. Epub 2012 Mar 15.

Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446382PMC
March 2012

FOXA1 is an independent prognostic marker for ER-positive breast cancer.

Breast Cancer Res Treat 2012 Feb 19;131(3):881-90. Epub 2011 Apr 19.

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 635 Barnhill Drive, MS-A128, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1482-6DOI Listing
February 2012

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.

Breast Cancer Res Treat 2012 Feb 15;132(1):131-42. Epub 2011 May 15.

Division of Medical Oncology, BC Cancer Agency, Cancer Agency, 600 W 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1529-8DOI Listing
February 2012

A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.

J Pathol 2012 Jan 26;226(1):97-107. Epub 2011 Sep 26.

Department of Oncology, University of Cambridge, Cambridge, CB1 9RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2976DOI Listing
January 2012

Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Sci Transl Med 2011 Nov;3(108):108ra113

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3002564DOI Listing
November 2011

Calculator for ovarian carcinoma subtype prediction.

Mod Pathol 2011 Apr 3;24(4):512-21. Epub 2010 Dec 3.

Genetic Pathology Evaluation Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.215DOI Listing
April 2011

Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypes.

Arch Pathol Lab Med 2011 Apr;135(4):433-9

Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/2010-0038-OA.1DOI Listing
April 2011

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.

Mod Pathol 2011 Jan 17;24(1):64-81. Epub 2010 Sep 17.

Molecular Oncology Department, BC Cancer Research Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.189DOI Listing
January 2011

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Am J Surg Pathol 2010 Dec;34(12):1805-11

Department of Pathology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181f7dae3DOI Listing
December 2010

Predictors of outcome following Gamma Knife surgery for acromegaly.

J Neurosurg 2010 Dec;113 Suppl:149-152

Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong SAR, People's Republic of Chna.

View Article

Download full-text PDF

Source
December 2010

Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes.

Breast Cancer Res Treat 2010 Nov 23;124(2):327-35. Epub 2010 Jan 23.

Department of Medicine, Indiana University School of Medicine, Walther Hall, 980 W Walnut Street, C230, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0733-2DOI Listing
November 2010

Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.

Breast Cancer Res 2010 14;12(1):R6. Epub 2010 Jan 14.

Department of Pharmacology, University of Wisconsin Medical School, 1300 University Avenue, Madison, Wisconsin 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880426PMC
August 2010

Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.

Breast Cancer Res Treat 2010 Jun 28;121(2):347-54. Epub 2009 Jul 28.

Center for Translational and Applied Genomics, British Columbia Cancer Agency, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0479-x
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0479-xDOI Listing
June 2010

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.

Ann Surg 2010 Jun;251(6):1107-16

Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e3181dbb77eDOI Listing
June 2010

Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience.

Hong Kong Med J 2010 Jun;16(3):186-91

Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong.

View Article

Download full-text PDF

Source
June 2010

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.

Breast Cancer Res Treat 2010 Jan 10;119(1):53-61. Epub 2009 Feb 10.

Genetic Pathology Evaluation Centre at Vancouver General Hospital, Prostate Center, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0318-0DOI Listing
January 2010

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

J Natl Cancer Inst 2009 May 12;101(10):736-50. Epub 2009 May 12.

Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djp082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684553PMC
May 2009

BCL-2 expression is prognostic for improved survival in non-small cell lung cancer.

J Thorac Oncol 2009 Apr;4(4):486-91

Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318199e03aDOI Listing
April 2009

Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.

Int J Radiat Oncol Biol Phys 2009 Mar 23;73(4):1121-8. Epub 2008 Aug 23.

Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.05.023DOI Listing
March 2009

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Breast Cancer Res 2008 16;10(5):R86. Epub 2008 Oct 16.

Laboratory for Oncogenomic Research, Departments of Pediatrics and Experimental Medicine, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614522PMC
February 2009

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

PLoS Med 2008 Dec;5(12):e232

Department of Pathology, Genetic Pathology Evaluation Centre of the Prostate Research Centre, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.0050232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592352PMC
December 2008

Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

Cancer Res 2008 Oct;68(20):8210-20

Department of Cellular and Physiological Sciences, Life Sciences Institute, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0343DOI Listing
October 2008

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

Clin Breast Cancer 2008 Jun;8(3):249-56

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.028DOI Listing
June 2008

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Clin Cancer Res 2008 Mar;14(5):1368-76

Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1658DOI Listing
March 2008

Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.

Am J Surg Pathol 2007 Jan;31(1):26-32

Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000213319.04919.97DOI Listing
January 2007

Prolonged survival in a subgroup of patients with brain metastases treated by gamma knife surgery.

J Neurosurg 2005 Jan;102 Suppl:262-5

Gamma Knife Centre, Canossa Hospital, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/jns.2005.102.s_supplement.0262DOI Listing
January 2005

Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.

Int J Radiat Oncol Biol Phys 2004 May;59(1):21-7

Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2003.10.027DOI Listing
May 2004